Rank | Gene Set | Z-score |
---|---|---|
1 | * positive regulation by symbiont of host defense response (GO:0052509) | 6.96308148 |
2 | * modulation by symbiont of host defense response (GO:0052031) | 6.96308148 |
3 | * modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.96308148 |
4 | * modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.96308148 |
5 | * positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.96308148 |
6 | * modulation by symbiont of host immune response (GO:0052553) | 6.96308148 |
7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.82258170 |
8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.58064901 |
9 | * response to peptidoglycan (GO:0032494) | 5.48655838 |
10 | negative regulation of cell killing (GO:0031342) | 5.47839202 |
11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.47839202 |
12 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 5.46803284 |
13 | neutrophil activation involved in immune response (GO:0002283) | 5.44747651 |
14 | * macrophage activation involved in immune response (GO:0002281) | 5.20761081 |
15 | positive regulation of interferon-alpha production (GO:0032727) | 5.06927545 |
16 | regulation of interferon-alpha production (GO:0032647) | 4.87401313 |
17 | * negative regulation of interleukin-12 production (GO:0032695) | 4.85715678 |
18 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.68737385 |
19 | * response to host immune response (GO:0052572) | 4.46600589 |
20 | * response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.46600589 |
21 | immunoglobulin mediated immune response (GO:0016064) | 4.36639439 |
22 | detection of bacterium (GO:0016045) | 4.31558095 |
23 | * lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.25851869 |
24 | response to muramyl dipeptide (GO:0032495) | 4.24974793 |
25 | respiratory burst (GO:0045730) | 4.22101892 |
26 | positive regulation of heat generation (GO:0031652) | 4.16255396 |
27 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.15183167 |
28 | * detection of external biotic stimulus (GO:0098581) | 4.12124271 |
29 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.10851484 |
30 | * microglial cell activation (GO:0001774) | 4.08415995 |
31 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.07879939 |
32 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.02201714 |
33 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.00633968 |
34 | regulation of gamma-delta T cell activation (GO:0046643) | 3.99109818 |
35 | * response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.96943076 |
36 | * response to host (GO:0075136) | 3.96943076 |
37 | * response to host defenses (GO:0052200) | 3.96943076 |
38 | granulocyte activation (GO:0036230) | 3.93365662 |
39 | regulation of fever generation (GO:0031620) | 3.88527328 |
40 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.85453297 |
41 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.81800788 |
42 | regulation of chemokine biosynthetic process (GO:0045073) | 3.76592273 |
43 | * macrophage activation (GO:0042116) | 3.72406168 |
44 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.70463359 |
45 | neutrophil activation (GO:0042119) | 3.70392314 |
46 | * detection of biotic stimulus (GO:0009595) | 3.70260003 |
47 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.63231897 |
48 | reactive oxygen species biosynthetic process (GO:1903409) | 3.57757949 |
49 | superoxide anion generation (GO:0042554) | 3.57615039 |
50 | * myeloid cell activation involved in immune response (GO:0002275) | 3.57409137 |
51 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.54417722 |
52 | leukocyte aggregation (GO:0070486) | 3.52773473 |
53 | regulation of mononuclear cell migration (GO:0071675) | 3.51977598 |
54 | positive regulation of mast cell degranulation (GO:0043306) | 3.51093943 |
55 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.51093943 |
56 | negative regulation of T cell mediated immunity (GO:0002710) | 3.48071338 |
57 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.46195968 |
58 | positive regulation of mast cell activation (GO:0033005) | 3.43137279 |
59 | germinal center formation (GO:0002467) | 3.42848385 |
60 | negative regulation of lipid storage (GO:0010888) | 3.42377427 |
61 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.40480331 |
62 | * positive regulation of interferon-beta production (GO:0032728) | 3.40452264 |
63 | defense response to protozoan (GO:0042832) | 3.39283325 |
64 | regulation of cholesterol storage (GO:0010885) | 3.35451905 |
65 | positive regulation of antigen processing and presentation (GO:0002579) | 3.32642244 |
66 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.32502044 |
67 | myeloid leukocyte mediated immunity (GO:0002444) | 3.30078974 |
68 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.29054340 |
69 | regulation of mast cell degranulation (GO:0043304) | 3.27155541 |
70 | regulation of leukocyte degranulation (GO:0043300) | 3.26787829 |
71 | cellular extravasation (GO:0045123) | 3.24247963 |
72 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.22026011 |
73 | * positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.21519741 |
74 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.20274739 |
75 | regulation of tolerance induction (GO:0002643) | 3.19793220 |
76 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.18773821 |
77 | B cell mediated immunity (GO:0019724) | 3.18026801 |
78 | neutrophil mediated immunity (GO:0002446) | 3.15799519 |
79 | response to protozoan (GO:0001562) | 3.15129023 |
80 | regulation of heat generation (GO:0031650) | 3.13076689 |
81 | cellular response to type I interferon (GO:0071357) | 3.11076447 |
82 | type I interferon signaling pathway (GO:0060337) | 3.11076447 |
83 | regulation of T cell tolerance induction (GO:0002664) | 3.10060178 |
84 | cytokine secretion (GO:0050663) | 3.09547236 |
85 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.08648837 |
86 | monocyte chemotaxis (GO:0002548) | 3.08195900 |
87 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.07946162 |
88 | response to type I interferon (GO:0034340) | 3.07390716 |
89 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.06551758 |
90 | positive regulation of leukocyte degranulation (GO:0043302) | 3.05652497 |
91 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.05420657 |
92 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.05093046 |
93 | * positive regulation of chemokine production (GO:0032722) | 3.04168576 |
94 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.02502947 |
95 | regulation of mast cell activation (GO:0033003) | 3.02190713 |
96 | regulation of podosome assembly (GO:0071801) | 3.02020014 |
97 | * detection of molecule of bacterial origin (GO:0032490) | 3.00714259 |
98 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.00206038 |
99 | * regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.00022916 |
100 | detection of other organism (GO:0098543) | 2.97804325 |
101 | positive regulation of type 2 immune response (GO:0002830) | 2.97628829 |
102 | T-helper 1 type immune response (GO:0042088) | 2.96867353 |
103 | lymphocyte chemotaxis (GO:0048247) | 2.96719338 |
104 | response to interleukin-15 (GO:0070672) | 2.96264123 |
105 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.95603513 |
106 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.94524235 |
107 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.94461733 |
108 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.91590934 |
109 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.91065677 |
110 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.90406772 |
111 | leukocyte cell-cell adhesion (GO:0007159) | 2.89750947 |
112 | response to interferon-alpha (GO:0035455) | 2.88594040 |
113 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.88299414 |
114 | cell adhesion mediated by integrin (GO:0033627) | 2.88272264 |
115 | leukocyte degranulation (GO:0043299) | 2.88107591 |
116 | negative regulation of interleukin-6 production (GO:0032715) | 2.86681248 |
117 | modulation by symbiont of host cellular process (GO:0044068) | 2.86486460 |
118 | neutrophil chemotaxis (GO:0030593) | 2.86406184 |
119 | apoptotic cell clearance (GO:0043277) | 2.86251587 |
120 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.85692841 |
121 | * positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.84236977 |
122 | leukocyte mediated cytotoxicity (GO:0001909) | 2.82875683 |
123 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.82797012 |
124 | natural killer cell mediated immunity (GO:0002228) | 2.82598183 |
125 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.82598183 |
126 | cellular response to exogenous dsRNA (GO:0071360) | 2.81990615 |
127 | T cell migration (GO:0072678) | 2.80750019 |
128 | * cellular response to lipopolysaccharide (GO:0071222) | 2.80525984 |
129 | * regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.80399639 |
130 | * positive regulation of interleukin-6 production (GO:0032755) | 2.79962429 |
131 | * positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.79859501 |
132 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.79414184 |
133 | negative regulation of viral genome replication (GO:0045071) | 2.79163140 |
134 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.79084386 |
135 | regulation of antigen processing and presentation (GO:0002577) | 2.78826253 |
136 | neutrophil migration (GO:1990266) | 2.78078182 |
137 | * cellular response to molecule of bacterial origin (GO:0071219) | 2.78027959 |
138 | * myeloid leukocyte activation (GO:0002274) | 2.77881788 |
139 | regulation of regulated secretory pathway (GO:1903305) | 2.77287033 |
140 | granulocyte chemotaxis (GO:0071621) | 2.75451154 |
141 | regulation of type 2 immune response (GO:0002828) | 2.75400775 |
142 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.74534622 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.92427379 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.88611617 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.45076771 |
4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.61028807 |
5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.46838975 |
6 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.94649093 |
7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.88695474 |
8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.56047325 |
9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.54251012 |
10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.35171100 |
11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.25087555 |
12 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.20007088 |
13 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.15641339 |
14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.12701859 |
15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.95193758 |
16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.69671578 |
17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.66258315 |
18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.45233467 |
19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.42405422 |
20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.31827124 |
21 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.28084268 |
22 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.22786478 |
23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.07112325 |
24 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.87621581 |
25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.87130012 |
26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.85004804 |
27 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.84330969 |
28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.76606893 |
29 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.76401292 |
30 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.76163371 |
31 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.74296243 |
32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.72095640 |
33 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.71783123 |
34 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.67871743 |
35 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.67852554 |
36 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.66445593 |
37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.65766953 |
38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.60484921 |
39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59527684 |
40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.54559013 |
41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48903052 |
42 | MYB_26560356_Chip-Seq_TH2_Human | 1.47739266 |
43 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.47342868 |
44 | MYC_22102868_ChIP-Seq_BL_Human | 1.42590393 |
45 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.42082649 |
46 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.39924461 |
47 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38778929 |
48 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.37264934 |
49 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37103222 |
50 | MAF_26560356_Chip-Seq_TH1_Human | 1.32648226 |
51 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.32346248 |
52 | MAF_26560356_Chip-Seq_TH2_Human | 1.32212501 |
53 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.30950952 |
54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30014036 |
55 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.27705787 |
56 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25880592 |
57 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.25467683 |
58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25181289 |
59 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24427472 |
60 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23517664 |
61 | MYB_26560356_Chip-Seq_TH1_Human | 1.19873961 |
62 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18550958 |
63 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17381063 |
64 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.17281378 |
65 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.15422685 |
66 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15071358 |
67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12626186 |
68 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.08322632 |
69 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.07678632 |
70 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.02963974 |
71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02169361 |
72 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01306045 |
73 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00682796 |
74 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99098807 |
75 | UTX_26944678_Chip-Seq_JUKART_Human | 0.96477287 |
76 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.96461654 |
77 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.96452317 |
78 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95053541 |
79 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.94572282 |
80 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93980491 |
81 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92205868 |
82 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.91600656 |
83 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88583048 |
84 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88494249 |
85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88375462 |
86 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86486419 |
87 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.86303084 |
88 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85825208 |
89 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85825208 |
90 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.85763231 |
91 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84837562 |
92 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84086411 |
93 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83861684 |
94 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.83062330 |
95 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82651330 |
96 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.81557149 |
97 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.81153060 |
98 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.81153060 |
99 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.80304026 |
100 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.79963747 |
101 | GATA2_19941826_ChIP-Seq_K562_Human | 0.79557957 |
102 | CJUN_26792858_Chip-Seq_BT549_Human | 0.78383270 |
103 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.75730220 |
104 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.74455496 |
105 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.74280185 |
106 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74146627 |
107 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73538952 |
108 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.73174859 |
109 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.72950823 |
110 | GATA1_19941826_ChIP-Seq_K562_Human | 0.71851046 |
111 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.71570095 |
112 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.71281991 |
113 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.70114045 |
114 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.69168483 |
115 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.68899449 |
116 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.68066715 |
117 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.67662136 |
118 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.67508689 |
119 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.66736332 |
120 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.66046098 |
121 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.65365265 |
122 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.63440607 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003436_decreased_susceptibility_to | 4.25338271 |
2 | MP0003303_peritoneal_inflammation | 3.92594346 |
3 | MP0001835_abnormal_antigen_presentation | 3.91522311 |
4 | * MP0009785_altered_susceptibility_to | 3.61985310 |
5 | MP0006082_CNS_inflammation | 3.42652706 |
6 | MP0002148_abnormal_hypersensitivity_rea | 3.39608678 |
7 | MP0005058_abnormal_lysosome_morphology | 3.35283558 |
8 | * MP0002419_abnormal_innate_immunity | 3.34644397 |
9 | MP0003724_increased_susceptibility_to | 3.33584113 |
10 | MP0005000_abnormal_immune_tolerance | 3.18648233 |
11 | * MP0005025_abnormal_response_to | 2.80839114 |
12 | MP0005387_immune_system_phenotype | 2.62809082 |
13 | MP0001790_abnormal_immune_system | 2.62809082 |
14 | MP0004510_myositis | 2.58654499 |
15 | * MP0002452_abnormal_antigen_presenting | 2.55516093 |
16 | MP0003172_abnormal_lysosome_physiology | 2.49627197 |
17 | MP0001533_abnormal_skeleton_physiology | 2.38955264 |
18 | * MP0002723_abnormal_immune_serum | 2.38423883 |
19 | MP0003191_abnormal_cellular_cholesterol | 2.29236903 |
20 | * MP0001800_abnormal_humoral_immune | 2.26550766 |
21 | MP0005464_abnormal_platelet_physiology | 2.17815971 |
22 | MP0000685_abnormal_immune_system | 2.14835637 |
23 | MP0009278_abnormal_bone_marrow | 2.12393296 |
24 | * MP0001819_abnormal_immune_cell | 2.06329720 |
25 | MP0005167_abnormal_blood-brain_barrier | 2.03744376 |
26 | * MP0002420_abnormal_adaptive_immunity | 2.03207292 |
27 | MP0004947_skin_inflammation | 2.01436389 |
28 | MP0000343_altered_response_to | 2.00005582 |
29 | MP0003448_altered_tumor_morphology | 1.98608148 |
30 | MP0009840_abnormal_foam_cell | 1.97018086 |
31 | MP0005671_abnormal_response_to | 1.95933426 |
32 | MP0001845_abnormal_inflammatory_respons | 1.88411262 |
33 | * MP0008469_abnormal_protein_level | 1.75584752 |
34 | MP0002405_respiratory_system_inflammati | 1.74225622 |
35 | MP0000604_amyloidosis | 1.72373998 |
36 | MP0003300_gastrointestinal_ulcer | 1.71323583 |
37 | * MP0009764_decreased_sensitivity_to | 1.70322651 |
38 | MP0005451_abnormal_body_composition | 1.66323860 |
39 | * MP0003075_altered_response_to | 1.63829022 |
40 | MP0001853_heart_inflammation | 1.62428185 |
41 | MP0002998_abnormal_bone_remodeling | 1.58975564 |
42 | MP0010155_abnormal_intestine_physiology | 1.55481966 |
43 | MP0003828_pulmonary_edema | 1.49944284 |
44 | MP0003690_abnormal_glial_cell | 1.46427331 |
45 | MP0000858_altered_metastatic_potential | 1.40821110 |
46 | MP0003183_abnormal_peptide_metabolism | 1.39571762 |
47 | MP0003763_abnormal_thymus_physiology | 1.38268336 |
48 | MP0005076_abnormal_cell_differentiation | 1.38164422 |
49 | MP0005397_hematopoietic_system_phenotyp | 1.38060765 |
50 | MP0001545_abnormal_hematopoietic_system | 1.38060765 |
51 | * MP0000716_abnormal_immune_system | 1.37416247 |
52 | MP0002006_tumorigenesis | 1.37390731 |
53 | MP0002254_reproductive_system_inflammat | 1.33507516 |
54 | MP0008004_abnormal_stomach_pH | 1.29903902 |
55 | MP0005164_abnormal_response_to | 1.29126951 |
56 | MP0009333_abnormal_splenocyte_physiolog | 1.28046684 |
57 | MP0005310_abnormal_salivary_gland | 1.26570741 |
58 | MP0002132_abnormal_respiratory_system | 1.24524401 |
59 | MP0002398_abnormal_bone_marrow | 1.21812376 |
60 | MP0005390_skeleton_phenotype | 1.19801215 |
61 | * MP0005166_decreased_susceptibility_to | 1.18963556 |
62 | MP0003195_calcinosis | 1.13025674 |
63 | MP0002277_abnormal_respiratory_mucosa | 1.12077868 |
64 | MP0004782_abnormal_surfactant_physiolog | 1.11874631 |
65 | MP0000689_abnormal_spleen_morphology | 1.10813081 |
66 | MP0000569_abnormal_digit_pigmentation | 1.09697745 |
67 | * MP0002429_abnormal_blood_cell | 1.08100123 |
68 | MP0003866_abnormal_defecation | 1.06214670 |
69 | MP0003806_abnormal_nucleotide_metabolis | 1.05117203 |
70 | MP0002933_joint_inflammation | 1.00752324 |
71 | MP0001851_eye_inflammation | 1.00172474 |
72 | MP0006054_spinal_hemorrhage | 0.98525078 |
73 | MP0000465_gastrointestinal_hemorrhage | 0.97905207 |
74 | MP0010307_abnormal_tumor_latency | 0.95805441 |
75 | MP0003453_abnormal_keratinocyte_physiol | 0.94233027 |
76 | MP0002722_abnormal_immune_system | 0.94144932 |
77 | MP0004381_abnormal_hair_follicle | 0.91403535 |
78 | * MP0009763_increased_sensitivity_to | 0.90976643 |
79 | MP0000703_abnormal_thymus_morphology | 0.90895563 |
80 | MP0000249_abnormal_blood_vessel | 0.90281807 |
81 | MP0003566_abnormal_cell_adhesion | 0.89663395 |
82 | MP0003656_abnormal_erythrocyte_physiolo | 0.88171167 |
83 | MP0008260_abnormal_autophagy | 0.87255059 |
84 | MP0004858_abnormal_nervous_system | 0.87157077 |
85 | MP0005257_abnormal_intraocular_pressure | 0.80714071 |
86 | MP0002396_abnormal_hematopoietic_system | 0.80102984 |
87 | MP0003795_abnormal_bone_structure | 0.79000733 |
88 | MP0009765_abnormal_xenobiotic_induced | 0.77944369 |
89 | MP0010352_gastrointestinal_tract_polyps | 0.76250260 |
90 | MP0000371_diluted_coat_color | 0.75555939 |
91 | MP0002166_altered_tumor_susceptibility | 0.75146471 |
92 | MP0002332_abnormal_exercise_endurance | 0.73427527 |
93 | MP0005023_abnormal_wound_healing | 0.73366165 |
94 | MP0003091_abnormal_cell_migration | 0.73269065 |
95 | MP0005174_abnormal_tail_pigmentation | 0.72664908 |
96 | MP0003221_abnormal_cardiomyocyte_apopto | 0.71853845 |
97 | MP0008874_decreased_physiological_sensi | 0.71178496 |
98 | MP0000767_abnormal_smooth_muscle | 0.70115301 |
99 | MP0004883_abnormal_blood_vessel | 0.69618226 |
100 | MP0003045_fibrosis | 0.67855613 |
101 | MP0008438_abnormal_cutaneous_collagen | 0.67519976 |
102 | MP0000015_abnormal_ear_pigmentation | 0.67406676 |
103 | MP0003186_abnormal_redox_activity | 0.67231321 |
104 | MP0000490_abnormal_crypts_of | 0.67025903 |
105 | MP0002090_abnormal_vision | 0.64106552 |
106 | MP0003329_amyloid_beta_deposits | 0.63849888 |
107 | MP0003705_abnormal_hypodermis_morpholog | 0.62481356 |
108 | MP0002136_abnormal_kidney_physiology | 0.61391535 |
109 | MP0005083_abnormal_biliary_tract | 0.58673982 |
110 | MP0000920_abnormal_myelination | 0.58429793 |
111 | MP0002138_abnormal_hepatobiliary_system | 0.57890193 |
112 | MP0005197_abnormal_uvea_morphology | 0.55810258 |
113 | MP0004130_abnormal_muscle_cell | 0.54391825 |
114 | MP0001663_abnormal_digestive_system | 0.54300745 |
115 | MP0004808_abnormal_hematopoietic_stem | 0.54004157 |
116 | * MP0008873_increased_physiological_sensi | 0.51421465 |
117 | MP0001873_stomach_inflammation | 0.50881791 |
118 | MP0002139_abnormal_hepatobiliary_system | 0.49247614 |
119 | MP0005376_homeostasis/metabolism_phenot | 0.48801887 |
120 | MP0000609_abnormal_liver_physiology | 0.48307552 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 7.51202097 |
2 | Eczematoid dermatitis (HP:0000976) | 6.81772206 |
3 | Recurrent bacterial skin infections (HP:0005406) | 6.75952199 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.23669588 |
5 | Abnormality of macrophages (HP:0004311) | 5.36420080 |
6 | Increased cerebral lipofuscin (HP:0011813) | 4.95656326 |
7 | Mediastinal lymphadenopathy (HP:0100721) | 4.89077339 |
8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.66723479 |
9 | Orchitis (HP:0100796) | 4.51571450 |
10 | Systemic lupus erythematosus (HP:0002725) | 4.49413226 |
11 | Stomatitis (HP:0010280) | 4.48691353 |
12 | Vacuolated lymphocytes (HP:0001922) | 4.42582668 |
13 | Myositis (HP:0100614) | 4.28227625 |
14 | Optic neuritis (HP:0100653) | 4.26893393 |
15 | Retrobulbar optic neuritis (HP:0100654) | 4.26893393 |
16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.14050118 |
17 | Recurrent skin infections (HP:0001581) | 4.11701374 |
18 | Gingivitis (HP:0000230) | 4.11593171 |
19 | Autoimmune thrombocytopenia (HP:0001973) | 3.90669001 |
20 | Axonal loss (HP:0003447) | 3.90217018 |
21 | Dysostosis multiplex (HP:0000943) | 3.69643917 |
22 | Gastrointestinal infarctions (HP:0005244) | 3.66213685 |
23 | Chronic obstructive pulmonary disease (HP:0006510) | 3.65647407 |
24 | Obstructive lung disease (HP:0006536) | 3.65647407 |
25 | Disinhibition (HP:0000734) | 3.63442939 |
26 | Prostate neoplasm (HP:0100787) | 3.51514396 |
27 | Abnormality of glycolipid metabolism (HP:0010969) | 3.50273935 |
28 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.50273935 |
29 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.50273935 |
30 | Recurrent fungal infections (HP:0002841) | 3.41828187 |
31 | Basal ganglia calcification (HP:0002135) | 3.37257810 |
32 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.34613853 |
33 | Glomerulonephritis (HP:0000099) | 3.31499729 |
34 | Thick nail (HP:0001805) | 3.24167534 |
35 | Encephalitis (HP:0002383) | 3.20006334 |
36 | Vasculitis (HP:0002633) | 3.17866777 |
37 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.09529671 |
38 | Mucopolysacchariduria (HP:0008155) | 3.09529671 |
39 | Myocardial infarction (HP:0001658) | 3.03604387 |
40 | Interstitial pulmonary disease (HP:0006530) | 2.98679451 |
41 | Pustule (HP:0200039) | 2.95949781 |
42 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.93837103 |
43 | Hematochezia (HP:0002573) | 2.92230891 |
44 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.91482758 |
45 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.91482758 |
46 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.91482758 |
47 | Pulmonary infiltrates (HP:0002113) | 2.90758996 |
48 | Periodontitis (HP:0000704) | 2.89720252 |
49 | T lymphocytopenia (HP:0005403) | 2.88119421 |
50 | Urticaria (HP:0001025) | 2.87610767 |
51 | Increased IgE level (HP:0003212) | 2.85677177 |
52 | Episodic fever (HP:0001954) | 2.84079692 |
53 | Recurrent viral infections (HP:0004429) | 2.83361895 |
54 | Agnosia (HP:0010524) | 2.83292512 |
55 | Cellulitis (HP:0100658) | 2.79915177 |
56 | Chest pain (HP:0100749) | 2.79656604 |
57 | Abnormality of T cell number (HP:0011839) | 2.73326785 |
58 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.67254169 |
59 | Joint hemorrhage (HP:0005261) | 2.66086269 |
60 | Prolonged bleeding time (HP:0003010) | 2.63001613 |
61 | Tetraparesis (HP:0002273) | 2.62349988 |
62 | Peritonitis (HP:0002586) | 2.62278062 |
63 | Pulmonary embolism (HP:0002204) | 2.58946234 |
64 | Recurrent cutaneous fungal infections (HP:0011370) | 2.58681631 |
65 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.58681631 |
66 | Gangrene (HP:0100758) | 2.56911816 |
67 | Osteomyelitis (HP:0002754) | 2.51220319 |
68 | Epistaxis (HP:0000421) | 2.50699868 |
69 | Arterial thrombosis (HP:0004420) | 2.46860702 |
70 | Osteolytic defects of the hand bones (HP:0009699) | 2.46631195 |
71 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.46631195 |
72 | Keratoconjunctivitis sicca (HP:0001097) | 2.44099596 |
73 | Increased serum ferritin (HP:0003281) | 2.37412421 |
74 | Leukocytosis (HP:0001974) | 2.37395238 |
75 | Increased IgM level (HP:0003496) | 2.36578550 |
76 | Meningitis (HP:0001287) | 2.34510043 |
77 | Hypochromic microcytic anemia (HP:0004840) | 2.32498073 |
78 | Recurrent pneumonia (HP:0006532) | 2.32179828 |
79 | Nephritis (HP:0000123) | 2.30221548 |
80 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.27232408 |
81 | Bone pain (HP:0002653) | 2.26689536 |
82 | Pathologic fracture (HP:0002756) | 2.26660039 |
83 | Purpura (HP:0000979) | 2.26357478 |
84 | Hepatosplenomegaly (HP:0001433) | 2.25618974 |
85 | Vertebral compression fractures (HP:0002953) | 2.24795769 |
86 | Inflammation of the large intestine (HP:0002037) | 2.22435993 |
87 | Hemoptysis (HP:0002105) | 2.22188811 |
88 | Upper motor neuron abnormality (HP:0002127) | 2.22168731 |
89 | Abnormality of the endocardium (HP:0004306) | 2.19821600 |
90 | Keratoconjunctivitis (HP:0001096) | 2.19443892 |
91 | Loss of speech (HP:0002371) | 2.17855635 |
92 | Vertigo (HP:0002321) | 2.17353983 |
93 | Polyneuropathy (HP:0001271) | 2.17346418 |
94 | Nausea (HP:0002018) | 2.17102876 |
95 | Premature loss of primary teeth (HP:0006323) | 2.13290617 |
96 | Abnormality of iron homeostasis (HP:0011031) | 2.12837941 |
97 | Hypochromic anemia (HP:0001931) | 2.12831504 |
98 | Glomerulopathy (HP:0100820) | 2.10667596 |
99 | Esophageal neoplasm (HP:0100751) | 2.09708116 |
100 | Neoplasm of head and neck (HP:0012288) | 2.09708116 |
101 | Abnormality of T cells (HP:0002843) | 2.09140223 |
102 | Gastrointestinal inflammation (HP:0004386) | 2.09047054 |
103 | Granulocytopenia (HP:0001913) | 2.06798884 |
104 | Abnormality of the peritoneum (HP:0002585) | 2.06470103 |
105 | Mutism (HP:0002300) | 2.05407789 |
106 | Peripheral demyelination (HP:0011096) | 2.04363480 |
107 | Apathy (HP:0000741) | 2.02693591 |
108 | Amyloidosis (HP:0011034) | 2.02306576 |
109 | Sepsis (HP:0100806) | 2.01949256 |
110 | Slow saccadic eye movements (HP:0000514) | 2.01819877 |
111 | Acne (HP:0001061) | 2.00869613 |
112 | Diminished motivation (HP:0000745) | 1.99785570 |
113 | Hypergammaglobulinemia (HP:0010702) | 1.98221030 |
114 | Recurrent lower respiratory tract infections (HP:0002783) | 1.97824596 |
115 | Gingival bleeding (HP:0000225) | 1.96534579 |
116 | Progressive visual loss (HP:0000529) | 1.96131902 |
117 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.95236675 |
118 | Spontaneous hematomas (HP:0007420) | 1.92691479 |
119 | Keratitis (HP:0000491) | 1.92646680 |
120 | Colitis (HP:0002583) | 1.90498096 |
121 | Abnormality of the pericardium (HP:0001697) | 1.88675076 |
122 | Anorexia (HP:0002039) | 1.88506747 |
123 | Abnormality of the prostate (HP:0008775) | 1.87418457 |
124 | Eosinophilia (HP:0001880) | 1.87388094 |
125 | Arthralgia (HP:0002829) | 1.85897976 |
126 | Cheilitis (HP:0100825) | 1.85489779 |
127 | J-shaped sella turcica (HP:0002680) | 1.84982686 |
128 | Abnormality of complement system (HP:0005339) | 1.84322981 |
129 | Retinal atrophy (HP:0001105) | 1.82516396 |
130 | Petechiae (HP:0000967) | 1.81505134 |
131 | Poor head control (HP:0002421) | 1.80951699 |
132 | Chronic otitis media (HP:0000389) | 1.73958140 |
133 | Inappropriate behavior (HP:0000719) | 1.73882262 |
134 | Abnormality of the pleura (HP:0002103) | 1.73745923 |
135 | Skin ulcer (HP:0200042) | 1.73171991 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 4.51446934 |
2 | MAP3K14 | 4.19527643 |
3 | TBK1 | 3.77375738 |
4 | IRAK3 | 3.74659694 |
5 | IRAK4 | 3.33865087 |
6 | BLK | 3.18385959 |
7 | TYK2 | 3.04787851 |
8 | MAP4K1 | 2.91798100 |
9 | IKBKE | 2.56817000 |
10 | ERN1 | 2.56217501 |
11 | TGFBR2 | 2.39311039 |
12 | IKBKB | 2.36779201 |
13 | TXK | 2.24554865 |
14 | PRPF4B | 2.08131913 |
15 | KIT | 2.01390824 |
16 | JAK3 | 1.91778441 |
17 | JAK1 | 1.84743403 |
18 | TAOK1 | 1.84173779 |
19 | CSK | 1.76709497 |
20 | FGR | 1.66253375 |
21 | TNK2 | 1.55941671 |
22 | PBK | 1.54003785 |
23 | GRK6 | 1.51905186 |
24 | PIM2 | 1.49026578 |
25 | CHUK | 1.40215068 |
26 | MAP3K13 | 1.38112000 |
27 | CSF1R | 1.35709304 |
28 | HCK | 1.35449101 |
29 | ZAP70 | 1.35138284 |
30 | RPS6KA4 | 1.32826567 |
31 | NME2 | 1.30988370 |
32 | EPHB1 | 1.25803271 |
33 | MATK | 1.24602408 |
34 | STK10 | 1.22310300 |
35 | SYK | 1.21246249 |
36 | RIPK1 | 1.17910098 |
37 | LYN | 1.17247346 |
38 | MARK3 | 1.14982703 |
39 | JAK2 | 1.13897123 |
40 | GRK7 | 1.08538015 |
41 | PIM1 | 1.08159299 |
42 | MAP3K3 | 1.06985978 |
43 | SIK3 | 1.06295443 |
44 | CAMK1D | 1.04598026 |
45 | ABL2 | 1.03949430 |
46 | LCK | 1.02775661 |
47 | FES | 1.01565838 |
48 | NEK9 | 0.98701295 |
49 | MAP3K10 | 0.98018222 |
50 | MAP2K3 | 0.97414350 |
51 | BMX | 0.92522959 |
52 | EIF2AK2 | 0.91918112 |
53 | BTK | 0.89107587 |
54 | CDC42BPA | 0.86233420 |
55 | MAP3K11 | 0.85709447 |
56 | MAP3K2 | 0.84704560 |
57 | TAOK3 | 0.84656025 |
58 | MAP3K6 | 0.84446860 |
59 | MST4 | 0.83559977 |
60 | PRKCD | 0.81462229 |
61 | IRAK1 | 0.79069677 |
62 | MARK2 | 0.78325525 |
63 | EGFR | 0.75635611 |
64 | MAP3K5 | 0.74059998 |
65 | MOS | 0.73816665 |
66 | IRAK2 | 0.73664329 |
67 | BMPR2 | 0.73298690 |
68 | STK3 | 0.72637280 |
69 | TTN | 0.69305531 |
70 | TEC | 0.68700898 |
71 | ABL1 | 0.68235208 |
72 | CAMKK2 | 0.64464020 |
73 | MST1R | 0.63739677 |
74 | TRIB3 | 0.61412283 |
75 | YES1 | 0.61395867 |
76 | PTK6 | 0.60172746 |
77 | KSR1 | 0.57831319 |
78 | LRRK2 | 0.57370581 |
79 | FGFR3 | 0.56052275 |
80 | ITK | 0.54765390 |
81 | DDR2 | 0.54481917 |
82 | CLK1 | 0.54248185 |
83 | TAOK2 | 0.54228078 |
84 | PKN2 | 0.52991409 |
85 | ARAF | 0.52506537 |
86 | ACVR1B | 0.52319957 |
87 | TESK2 | 0.52266272 |
88 | SGK3 | 0.52179331 |
89 | MAPK7 | 0.51447957 |
90 | PAK4 | 0.50093955 |
91 | MAPK12 | 0.49870306 |
92 | DAPK2 | 0.49598609 |
93 | PRKD2 | 0.49578852 |
94 | MAP3K1 | 0.48824674 |
95 | MAP2K6 | 0.48722362 |
96 | STK24 | 0.48460809 |
97 | TRPM7 | 0.47368262 |
98 | HIPK2 | 0.46033109 |
99 | RPS6KA6 | 0.45485802 |
100 | RAF1 | 0.44862451 |
101 | SIK2 | 0.44688276 |
102 | MAP2K4 | 0.44681795 |
103 | STK4 | 0.42152274 |
104 | KSR2 | 0.41988398 |
105 | PTK2B | 0.41363074 |
106 | CAMK1G | 0.39951323 |
107 | DYRK1B | 0.39815897 |
108 | DAPK3 | 0.39755129 |
109 | FYN | 0.39565288 |
110 | MAPKAPK2 | 0.39440145 |
111 | GSK3A | 0.36608287 |
112 | SCYL2 | 0.36064140 |
113 | FGFR4 | 0.36054272 |
114 | CDK6 | 0.34837785 |
115 | PDK1 | 0.34194401 |
116 | PIK3CG | 0.34085882 |
117 | STK11 | 0.33987908 |
118 | SGK2 | 0.33853313 |
119 | PDGFRB | 0.33264717 |
120 | DYRK3 | 0.33095400 |
121 | PRKG2 | 0.32907213 |
122 | RPS6KL1 | 0.31224772 |
123 | RPS6KC1 | 0.31224772 |
124 | PRKCQ | 0.31192922 |
125 | PDPK1 | 0.31161778 |
126 | RET | 0.31009920 |
127 | ERBB4 | 0.30819154 |
128 | CAMKK1 | 0.30741505 |
129 | EPHA3 | 0.28846563 |
130 | MAPK4 | 0.28656567 |
131 | INSR | 0.27954126 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.62095295 |
2 | * Leishmaniasis_Homo sapiens_hsa05140 | 3.42447570 |
3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.99083047 |
4 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.90051059 |
5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.75239876 |
6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.65572602 |
7 | * Legionellosis_Homo sapiens_hsa05134 | 2.60307471 |
8 | Pertussis_Homo sapiens_hsa05133 | 2.56113497 |
9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.42237157 |
10 | * Tuberculosis_Homo sapiens_hsa05152 | 2.38331392 |
11 | * Malaria_Homo sapiens_hsa05144 | 2.32697007 |
12 | Lysosome_Homo sapiens_hsa04142 | 2.26709756 |
13 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.26037447 |
14 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.05796947 |
15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.05275083 |
16 | Allograft rejection_Homo sapiens_hsa05330 | 2.01696881 |
17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.99741642 |
18 | * Phagosome_Homo sapiens_hsa04145 | 1.94545527 |
19 | Asthma_Homo sapiens_hsa05310 | 1.91425179 |
20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.90125089 |
21 | Influenza A_Homo sapiens_hsa05164 | 1.82141017 |
22 | Salmonella infection_Homo sapiens_hsa05132 | 1.81522820 |
23 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.81272797 |
24 | * Measles_Homo sapiens_hsa05162 | 1.78441381 |
25 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.76574871 |
26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.75895075 |
27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.67191210 |
28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.62663024 |
29 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.61471003 |
30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.61235020 |
31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.44235981 |
32 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.41633775 |
33 | Apoptosis_Homo sapiens_hsa04210 | 1.32981737 |
34 | Shigellosis_Homo sapiens_hsa05131 | 1.31645703 |
35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.31160560 |
36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.27944715 |
37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.22772918 |
38 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.22733908 |
39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.21535150 |
40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20382347 |
41 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11381465 |
42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.08284443 |
43 | Hepatitis C_Homo sapiens_hsa05160 | 1.06850900 |
44 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.01864449 |
45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.00653550 |
46 | * Amoebiasis_Homo sapiens_hsa05146 | 1.00472024 |
47 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.98931220 |
48 | * Hepatitis B_Homo sapiens_hsa05161 | 0.98623202 |
49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.98362454 |
50 | Prion diseases_Homo sapiens_hsa05020 | 0.96060882 |
51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88331415 |
52 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.85053343 |
53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.80444607 |
54 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.78325128 |
55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.76189370 |
56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75396117 |
57 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.74442011 |
58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70866572 |
59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.69582998 |
60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69157351 |
61 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.68657350 |
62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66648959 |
63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66041176 |
64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61858198 |
65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61792891 |
66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60368895 |
67 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59601157 |
68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.58113429 |
69 | Bladder cancer_Homo sapiens_hsa05219 | 0.57587628 |
70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57292770 |
71 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.54605909 |
72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54311498 |
73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53193204 |
74 | Platelet activation_Homo sapiens_hsa04611 | 0.52806286 |
75 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.51885792 |
76 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50369592 |
77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48220904 |
78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42841299 |
79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42115406 |
80 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41023644 |
81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.39924437 |
82 | Mineral absorption_Homo sapiens_hsa04978 | 0.39388214 |
83 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39363226 |
84 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38791879 |
85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38346694 |
86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38202030 |
87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37631351 |
88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37568386 |
89 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37484761 |
90 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.37231092 |
91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35836357 |
92 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35324616 |
93 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.35059546 |
94 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.33592497 |
95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32836539 |
96 | Insulin resistance_Homo sapiens_hsa04931 | 0.32805025 |
97 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.32042138 |
98 | Endocytosis_Homo sapiens_hsa04144 | 0.31968084 |
99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.31836392 |
100 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.29459651 |
101 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.28856315 |
102 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.28836819 |
103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.26475775 |
104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25543397 |
105 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.24241977 |
106 | HTLV-I infection_Homo sapiens_hsa05166 | 0.22010162 |
107 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.19790054 |
108 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.19236182 |
109 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.18154638 |
110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.18009529 |
111 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.17524865 |
112 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.17524324 |
113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.16755829 |
114 | Focal adhesion_Homo sapiens_hsa04510 | 0.16515264 |